A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/03/2011	US20110269790 Novel thienopyridines as pharmacologically active agents
11/03/2011	US20110269789 Compositions and Methods for Achieving Sustained Therapeutic Drug Concentrations in a Subject
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269787 Azabicyclic Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
11/03/2011	US20110269786 Treatment of major adverse cardiac events and acute coronary syndrome in diabetic patients using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapies
11/03/2011	US20110269785 Substituted 2-Aminoacetamides and the Use Thereof
11/03/2011	US20110269784 Use of tetrahydropyrimidines
11/03/2011	US20110269783 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/03/2011	US20110269782 Use of nmda activity enhancers to treat hypersomnia, reduced wakefulness or reduced vigilance
11/03/2011	US20110269781 Compounds
11/03/2011	US20110269780 Aza-benzimidazolone chymase inhibitors
11/03/2011	US20110269779 Methods and compositions for treatment of ophthalmic conditions
11/03/2011	US20110269778 Novel diphenyl purine derivatives useful as modulators of nicotinic acetylcholine receptors
11/03/2011	US20110269777 Methods and compositions for treating schizophrenia using antipsychotic combination therapy
11/03/2011	US20110269776 Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
11/03/2011	US20110269775 Piperazine derivatives
11/03/2011	US20110269774 Pyrazolylaminopyridines as inhibitors of fak
11/03/2011	US20110269773 Dihydrofuro pyrimidines as akt protein kinase inhibitors
11/03/2011	US20110269772 Axl kinase inhibitors
11/03/2011	US20110269771 Pyridazinone derivatives
11/03/2011	US20110269770 Pyrazole Compounds for Controlling Invertebrate Pests
11/03/2011	US20110269769 Imidazole derivatives useful as inhibitors of faah
11/03/2011	US20110269768 Urotensin ii receptor antagonists
11/03/2011	US20110269767 Novel Polymorphic Forms of 3-(1--6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile Hydrochloride Salt and Processes of Manufacturing Thereof
11/03/2011	US20110269766 Benzimidazole-4-Carboxamide Derivatives, Their Preparation Methods, Pharmaceutical Compositions And Their Uses
11/03/2011	US20110269765 Pyridazinone derivatives
11/03/2011	US20110269764 Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of synapse function
11/03/2011	US20110269763 CRTH2 receptor ligands for medicinal uses
11/03/2011	US20110269762 Methods for treating atrial fibrillation and reducing stroke rate in atrial fibrillation patients
11/03/2011	US20110269761 Arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
11/03/2011	US20110269760 Tubulin inhibitors
11/03/2011	US20110269759 Pyrimidine compounds as delta opioid receptor modulators
11/03/2011	US20110269758 Naphthyridinones as protein kinase inhibitors
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269756 Benzothiazolone derivatives
11/03/2011	US20110269755 Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
11/03/2011	US20110269754 Compounds and compositions for reducing lipid levels
11/03/2011	US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors
11/03/2011	US20110269752 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
11/03/2011	US20110269750 Roflumilast for the treatment of diabetes mellitus
11/03/2011	US20110269749 Tricyclic carbamate jak inhibitors
11/03/2011	US20110269748 2-aniline-4-aryl substituted thiazole derivatives
11/03/2011	US20110269747 Polyarylcarboxamides useful as lipid lowering agents
11/03/2011	US20110269746 Cyclic compound having hetero atom
11/03/2011	US20110269745 6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
11/03/2011	US20110269744 Benzazepine Compound
11/03/2011	US20110269743 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
11/03/2011	US20110269742 Serotonin 5-HT2B Receptor Inhibitors
11/03/2011	US20110269741 Novel compositions and methods of use
11/03/2011	US20110269740 Jak kinase modulating compounds and methods of use thereof
11/03/2011	US20110269739 Kinase inhibitors
11/03/2011	US20110269738 Compounds
11/03/2011	US20110269737 7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases
11/03/2011	US20110269736 1,1'-Diadamantyl carboxylic acids, medicaments containing such compounds and their use
11/03/2011	US20110269735 Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
11/03/2011	US20110269734 Piperidinyl gpcr agonists
11/03/2011	US20110269733 Silent Desensitizers of Neuronal nAChR and Methods of Use Thereof
11/03/2011	US20110269732 Drug discovery methods
11/03/2011	US20110269731 Nanoparticles of beta-lactam derivatives
11/03/2011	US20110269730 Metal Complexes of Thiourea and Derivatives as Metal Delivering Anti-Cancer and Anti-Inflammatory Agents
11/03/2011	US20110269729 Testosterone Gel And Method Of Use
11/03/2011	US20110269728 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
11/03/2011	US20110269727 Composition to reduce allodynic back pain and related method of use
11/03/2011	US20110269726 Method of and system for treatment of inflammatory skin conditions
11/03/2011	US20110269725 Novel estrogenic compounds
11/03/2011	US20110269724 Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries
11/03/2011	US20110269723 Spill resistant formulations containing clays
11/03/2011	US20110269722 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269721 Methods of treating thalassemia
11/03/2011	US20110269720 Minocycline and rifampin microparticles
11/03/2011	US20110269719 Pharmaceutical compositions with phosphonium antimicrobial agents
11/03/2011	US20110269718 Pharmaceutical composition containing malathion and volatile cyclic silicone
11/03/2011	US20110269717 Neurogenesis by modulating angiotensin
11/03/2011	US20110269716 Antioxidant compounds and methods of their use
11/03/2011	US20110269715 Abnormal cannabidiols as agents for lowering intraocular pressure
11/03/2011	US20110269714 Polycyclic Tetracycline Compounds
11/03/2011	US20110269713 Bryostatin analogues and methods of making and using thereof
11/03/2011	US20110269711 Methods and compositions for inducing satiety
11/03/2011	US20110269710 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
11/03/2011	US20110269709 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269708 P2x7 antagonists to treat affective disorders
11/03/2011	US20110269707 Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation
11/03/2011	US20110269706 Hydroxamic Acid Derivatives
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/03/2011	US20110269704 Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically
11/03/2011	US20110269703 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
11/03/2011	US20110269702 Polyacetylenic compounds for protecting against pancreatic islet atrophy
11/03/2011	US20110269701 7,2''-dehydrate puerarin and its salts, preparation method and use thereof
11/03/2011	US20110269700 Glucoside derivatives and uses thereof
11/03/2011	US20110269697 Organoarsenic compounds and methods for the treatment of cancer
11/03/2011	US20110269691 Compositions and Methods for Treating Pigmentary Conditions and Melanoma
11/03/2011	US20110269689 High penetration compositions and their applications
11/03/2011	US20110269688 Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same
11/03/2011	US20110269681 Prolactin Induced Increase in Neural Stem Cell Numbers
11/03/2011	US20110269678 Nutritional method
11/03/2011	US20110269677 Oligomer-Protease Inhibitor Conjugates
11/03/2011	US20110269675 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
11/03/2011	US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
11/03/2011	US20110269666 Method and drug composition for treating septic shock hypotension
11/03/2011	US20110269665 Compound and method for treating myotonic dystrophy

1 ... 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 ... 7860